Haemonetics Corp reports results for the quarter ended in June - Earnings Summary

Haemonetics

10/08/2022 12:38

* Haemonetics Corp  HAE.N  reported quarterly adjusted
earnings of
58 cents​​ per share for the quarter ended in June. The mean
expectation of seven analysts for the quarter was for earnings
of 51 cents per share.
    * Revenue rose 14.4% to $261.46 million from a year ago;
analysts
expected $249.00 million. 
    * Haemonetics Corp's reported EPS for the quarter was 38
cents​.
    * The mean earnings estimate of analysts had fallen by
about 14%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Haemonetics Corp shares had risen by 3.7% this quarter and
gained 27.4% so far this year.
    * The company reported quarterly net income of $19.88
million.
    * Wall Street's median 12-month price target for Haemonetics
Corp
is $76.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 10
at 11:38 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      0.51           0.58           Beat
 Mar. 31 2022      0.60           0.65           Beat
 Dec. 31 2021      0.73           0.84           Beat
 Sep. 30 2021      0.61           0.60           Missed